Radar map of the immuno-oncology market showing which companies count as part of it, which sit on its edge and which stay outside: Who is in immuno-oncology, and who stays outside? (Immuno-Oncology Market, NewMarketPitch)
01Market maps
Timeline of the dated steps showing how the immuno-oncology market is moving, with one key signal: Keytruda Qlex turned checkpoint therapy into a one minute shot (Immuno-Oncology Market, NewMarketPitch)
02Signals
Bar chart of the immuno-oncology market size year by year to 2036, with its growth rate: How much bigger can immuno-oncology get? (Immuno-Oncology Market, NewMarketPitch)
03Market data
Matrix of the problems immuno-oncology customers still face, rated for each type of buyer: Which immuno-oncology problems are still unsolved? (Immuno-Oncology Market, NewMarketPitch)
04Unsolved problems
Comparison table of the tech offered by leading immuno-oncology companies: Who has the most complete immuno-oncology tech today? (Immuno-Oncology Market, NewMarketPitch)
05Tech & infra
Log scale column chart of how much is paid at each step of the immuno-oncology market, from the smallest to the biggest amount: The further an immunotherapy gets, the more cash it brings (Immuno-Oncology Market, NewMarketPitch)
06Business models
Table of the events that could slow the immuno-oncology market, with their odds and impact: What are the biggest threats to the immuno-oncology market? (Immuno-Oncology Market, NewMarketPitch)
07All the risks
Timeline of the events that pushed the immuno-oncology market forward, with their impact: What pushed the immuno-oncology market forward, year after year? (Immuno-Oncology Market, NewMarketPitch)
08Growth drivers
Bar chart of where investors put their money in immuno-oncology, by category: Where did immuno-oncology investors put their money this past year? (Immuno-Oncology Market, NewMarketPitch)
09Latest investor bets
Market grid of the top immuno-oncology startups and companies by segment: Who are the top players in immuno-oncology today? (Immuno-Oncology Market, NewMarketPitch)
10Top players
Table of the warning signs shown by leading immuno-oncology companies: Which immuno-oncology companies have shown warning signs lately? (Immuno-Oncology Market, NewMarketPitch)
11Startup killers
Scorecard showing what sets the leading immuno-oncology company apart: How did Merck take the lead in PD-1 and PD-L1 drugs? (Immuno-Oncology Market, NewMarketPitch)
12Winning strategies

Immuno-Oncology market report

PRO pack · sections 1 to 3.

Choose your pack3 packs
Buy the PRO pack →
One-time payment
← Immuno-Oncology market page